8-K
filed February 23, 2023, 6:59 PM ET
ticker MPT
CIK 0001287865
earnings
confidence high
sentiment negative
materiality 0.80
MPT reports Q4 net loss of $0.24 per share; $171M impairment on Prospect properties
MEDICAL PROPERTIES TRUST INC
2022-FY EPS reported
$1.50
revenue$1,542,851,000
- Q4 2022 net loss of ($0.24) per diluted share; full-year net income $1.50 per share, up 35% YoY.
- NFFO per share $0.43 in Q4 and $1.82 for full year, up 4% YoY.
- Includes $171M real estate impairment and $112M write-off of unbilled rent related to Prospect Medical Holdings.
- Acquired six Priory behavioral health facilities in UK for £233M; expects ~$50M additional cash rent from escalators in 2023.
- Introduced 2023 guidance: net income per share $0.83-$0.98; NFFO per share $1.50-$1.65.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
MEDICAL PROPERTIES TRUST INC reported the fourth quarter ended December 31, 2022 results: net income ($140) million, EPS ($0.24) per diluted share. Guidance initiated.
- Period
- the fourth quarter ended December 31, 2022
- Net income
- ($140) million
- EPS
- ($0.24) per diluted share
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
Operating results for the fourth quarter and year ended December 31, 2022 were a net loss of ($140) million (($0.24) per diluted share) and net income of $903 million ($1.50 per diluted share), respectively, compared to net income of $207 million ($0.34 per diluted share) and $656 million ($1.11 per diluted share) in the year earlier periods.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
MEDICAL PROPERTIES TRUST INC reported the full-year ended December 31, 2022 results: net income $903 million, EPS $1.50 per diluted share. Guidance initiated.
- Period
- the full-year ended December 31, 2022
- Net income
- $903 million
- EPS
- $1.50 per diluted share
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
Operating results for the fourth quarter and year ended December 31, 2022 were a net loss of ($140) million (($0.24) per diluted share) and net income of $903 million ($1.50 per diluted share), respectively, compared to net income of $207 million ($0.34 per diluted share) and $656 million ($1.11 per diluted share) in the year earlier periods.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.